We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
lack of leadership combined with increasing pressure
to approve new drugs quickly and the Bush administration's antiregulatory philosophy
has left the FDA "timid and toothless," according to an editorial
in The New England Journal of Medicine (NEJM).
A federal district court judge has approved an amendment to the National Diet
Drug Settlement, moving Wyeth one step closer to settling with the largest group
of plaintiffs involved in a class action lawsuit over the company's fen-phen
products.
In a press release, the
biopharmaceutical company said the reductions will allow
the company to prepare for a planned partnership of Estrasorb, its
topical emulsion
for estrogen therapy.
A small group of Eli Lilly and Co.
shareholders that includes a nun and the
1,000-woman congregation of Adrian Dominican Sisters wants the
drugmaker to
split its corporate structure at the very top.
Drugmaker Pfizer Inc. announced Tuesday it
plans to end production at its Holland,
Mich., plant and sell off the facility. If a buyer cannot be found,
the facility
will be closed in late 2006.
Dutch biotechnology
company Crucell N.V. today announced the signing of a commercial
PER.C6 license agreement with Singapore-based company SingVax Pte Ltd
for the
development and commercialization of new vaccines against Japanese
encephalitis.
GlaxoSmithKline and Medco Health Solutions announced
an innovative collaboration
designed to provide broad access to GSK's medicines through Medco's
proposed
CMS offering as a National Prescription Drug Provider (PDP).
Biolex, a privately held protein therapeutics company,
announced a broad-based, multileveled strategic alliance with
Centocor, Inc.,
a leading biopharmaceutical company, to manufacture selected proteins
using
the Biolex LEX System.